OUTLOOK Price Fair Value from 2010 to 2024

OTLK Stock  USD 1.70  3.19  65.24%   
OUTLOOK THERAPEUTICS Price Fair Value yearly trend continues to be quite stable with very little volatility. Price Fair Value may rise above -3.27 this year. From the period between 2010 and 2024, OUTLOOK THERAPEUTICS, Price Fair Value regression line of its data series had standard deviation of  21.28 and standard deviation of  21.28. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
(3.45)
Current Value
(3.27)
Quarterly Volatility
21.28434317
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OUTLOOK THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OUTLOOK THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.8 K, Interest Expense of 1.9 M or Selling General Administrative of 16.7 M, as well as many indicators such as Price To Sales Ratio of 2.84, Dividend Yield of 12.5 K or Days Sales Outstanding of 190. OUTLOOK financial statements analysis is a perfect complement when working with OUTLOOK THERAPEUTICS Valuation or Volatility modules.
  
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.

Latest OUTLOOK THERAPEUTICS's Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of OUTLOOK THERAPEUTICS INC over the last few years. It is OUTLOOK THERAPEUTICS's Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OUTLOOK THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

OUTLOOK Price Fair Value Regression Statistics

Arithmetic Mean4.92
Geometric Mean4.92
Coefficient Of Variation432.70
Mean Deviation14.03
Median(2.11)
Standard Deviation21.28
Sample Variance453.02
Range85.9817
R-Value0.29
Mean Square Error446.14
R-Squared0.09
Significance0.29
Slope1.39
Total Sum of Squares6,342

OUTLOOK Price Fair Value History

2024 -3.27
2023 -3.45
2022 -3.83
2021 29.62
2020 71.91
2019 18.49
2018 -2.52

About OUTLOOK THERAPEUTICS Financial Statements

OUTLOOK THERAPEUTICS investors utilize fundamental indicators, such as Price Fair Value, to predict how OUTLOOK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price Fair Value(3.45)(3.27)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock:
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.89)
Revenue Per Share
0.119
Quarterly Revenue Growth
6.583
Return On Assets
(0.84)
Return On Equity
(0.04)
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.